Entering text into the input field will update the search result below

Aethlon's Hemopurifier shows ability to remove viral pathogens from blood samples; shares ahead 3%

Feb. 22, 2017 9:48 AM ETAethlon Medical, Inc. (AEMD) StockBy: Douglas W. House, SA News Editor2 Comments
  • Researchers at Aethlon Medical (NASDAQ:AEMD +3.4%) have demonstrated the ability of the Hemopurifier device to remove viral pathogens from blood samples obtained from organ transplant patients who were suffering from sepsis.
  • Results showed that the Hemopurifier was able to reduce the level of Herpes Simplex virus 1 (HSV1) by 72% after six hours. Levels of Epstein-Barr virus (EBV) and Cytomegalovirus (CMV) were reduced 77% and 88%, respectively.
  • Hemopurifier is a bio-filtration device designed to remove bioterror-related pathogens. Studies have also shown its ability to remove the Zika virus from serum.

Recommended For You

About AEMD Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
AEMD--
Aethlon Medical, Inc.